$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan

$loan Overview Financials Valuation SEC Filings Company Website

2014 Form 10-K Financial Statement

#000114420415017617 Filed on March 23, 2015

Income Statement

Concept	2014	2013 Q4	2013
Revenue	$2.900M	$590.0K	$2.260M
YoY Change	28.34%	13.46%	24.45%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$880.0K	$290.0K	$840.0K
YoY Change	4.76%	-9.38%	-2.33%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$880.0K	$280.0K	$840.0K
YoY Change	4.76%	-12.5%	-3.45%
Operating Profit	$1.461M		$977.4K
YoY Change	49.49%		47.12%
Interest Expense	-$560.0K	-$120.0K	-$440.0K
YoY Change	27.27%	33.33%	57.14%
% of Operating Profit	-38.33%		-45.02%
Other Income/Expense, Net	$21.20K	$10.00K	-$7.452K
YoY Change	-384.45%	0.0%	-127.05%
Pretax Income	$1.482M	$150.0K	$970.0K
YoY Change	52.82%	36.36%	40.18%
Income Tax	$27.84K	$90.00K	$387.0K
% Of Pretax Income	1.88%	60.0%	39.9%
Net Earnings	$1.455M	$60.00K	$583.0K
YoY Change	149.5%	100.0%	50.01%
Net Earnings / Revenue	50.16%	10.17%	25.8%
Basic Earnings Per Share	$0.29		$0.14
Diluted Earnings Per Share	$0.29	$13.99K	$0.14
COMMON SHARES
Basic Shares Outstanding	5.029M shares		4.269M shares
Diluted Shares Outstanding	5.058M shares		4.290M shares

Balance Sheet

Concept	2014	2013 Q4	2013
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.00K	$1.020M	$1.020M
YoY Change	-95.1%	325.0%	325.0%
Cash & Equivalents	$50.00K	$1.021M	$1.020M
Short-Term Investments
Other Short-Term Assets	$30.00K	$18.54K	$20.00K
YoY Change	50.0%	-1.92%	0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$19.43M	$11.91M	$11.91M
YoY Change	63.14%	4.07%	4.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.00K	$0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$70.00K	$210.0K	$210.0K
YoY Change	-66.67%	-16.0%	-16.0%
Other Assets	$40.00K	$0.00	$10.00K
YoY Change	300.0%	-100.0%	-80.0%
Total Long-Term Assets	$5.010M	$4.215M	$4.210M
YoY Change	19.0%	45.53%	45.17%
TOTAL ASSETS
Total Short-Term Assets	$19.43M	$11.91M	$11.91M
Total Long-Term Assets	$5.010M	$4.215M	$4.210M
Total Assets	$24.44M	$16.12M	$16.12M
YoY Change	51.61%	12.45%	12.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$160.0K	$60.00K	$60.00K
YoY Change	166.67%	-14.29%	-14.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$2.470M	$1.319M	$1.320M
YoY Change	87.12%	-5.72%	-30.53%
Long-Term Debt Due	$7.700M	$5.350M	$5.350M
YoY Change	43.93%	33.75%	52.86%
Total Short-Term Liabilities	$10.58M	$7.232M	$7.230M
YoY Change	46.33%	23.4%	23.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.58M	$7.232M	$7.230M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$10.58M	$7.230M	$7.230M
YoY Change	46.33%	23.38%	23.38%
SHAREHOLDERS EQUITY
Retained Earnings		-$487.7K
YoY Change		-48.26%
Common Stock		$9.750M
YoY Change		0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$369.3K
YoY Change		36.8%
Treasury Stock Shares		177.0K shares
Shareholders Equity	$13.87M	$8.893M	$8.890M
YoY Change
Total Liabilities & Shareholders Equity	$24.44M	$16.12M	$16.12M
YoY Change	51.61%	12.45%	12.41%

Cashflow Statement

Concept	2014	2013 Q4	2013
OPERATING ACTIVITIES
Net Income	$1.455M	$60.00K	$583.0K
YoY Change	149.5%	100.0%	50.01%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change
Cash From Operating Activities	$1.280M	$240.0K	$790.0K
YoY Change	62.03%	9.09%	49.06%
INVESTING ACTIVITIES
Capital Expenditures	$19.09K		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$9.190M	$710.0K	-$1.070M
YoY Change	758.88%	-175.53%	-74.58%
Cash From Investing Activities	-$9.210M	$710.0K	-$1.070M
YoY Change	760.75%	-175.53%	-74.58%
FINANCING ACTIVITIES
Cash Dividend Paid	$853.5K		$128.0K
YoY Change	566.69%
Common Stock Issuance & Retirement, Net	$4.289M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.960M	10.00K	1.070M
YoY Change	550.47%	-98.67%	-71.08%
NET CHANGE
Cash From Operating Activities	1.280M	240.0K	790.0K
Cash From Investing Activities	-9.210M	710.0K	-1.070M
Cash From Financing Activities	6.960M	10.00K	1.070M
Net Change In Cash	-970.0K	960.0K	790.0K
YoY Change	-222.78%	3100.0%	3850.0%
FREE CASH FLOW
Cash From Operating Activities	$1.280M	$240.0K	$790.0K
Capital Expenditures	$19.09K		$0.00
Free Cash Flow	$1.261M		$790.0K
YoY Change	59.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	us-gaap	Assets Assets	24444317	USD
CY2014Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	19138426	USD
CY2013Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	10697950	USD
CY2014Q4	us-gaap	Real Estate Investments RealEstateInvestments	0	USD
CY2013Q4	us-gaap	Real Estate Investments RealEstateInvestments	146821	USD
CY2014Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	4894050	USD
CY2013Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3997000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19088	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	USD
CY2014Q4	us-gaap	Security Deposit SecurityDeposit	6816	USD
CY2013Q4	us-gaap	Security Deposit SecurityDeposit	6637	USD
CY2014Q4	us-gaap	Cost Method Investments CostMethodInvestments	65000	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	65000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	32500	USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0	USD
CY2013Q4	us-gaap	Assets Assets	16124454	USD
CY2014Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	2469465	USD
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1319465	USD
CY2014Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7700000	USD
CY2013Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5350000	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	163622	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	57066	USD
CY2014Q4	loan	Deferred Origination Fees DeferredOriginationFees	244776	USD
CY2013Q4	loan	Deferred Origination Fees DeferredOriginationFees	132017	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	373219	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10577863	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7231767	USD
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014	loan	Interest Income From Loans InterestIncomeFromLoans	2401150	USD
CY2013	loan	Interest Income From Loans InterestIncomeFromLoans	1858033	USD
CY2014	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1442518	USD
CY2013	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1282128	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	1461147	USD
CY2014	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	563368	USD
CY2013	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	442661	USD
CY2014	loan	Referral Fees ReferralFees	2244	USD
CY2013	loan	Referral Fees ReferralFees	1679	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	876906	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	837788	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	977419	USD
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	21197	USD
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	27548	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14116183	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	369335	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	113346	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	13866454	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24444317	USD
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Entity Registrant Name EntityRegistrantName	MANHATTAN BRIDGE CAPITAL, INC
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001080340
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q2	dei	Entity Public Float EntityPublicFloat	5655524	USD
CY2014	dei	Trading Symbol TradingSymbol	LOAN
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6089089	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	6260	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	4433	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9745249	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	369335	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-487660	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	8892687	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16124454	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6260689	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4433190	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6083689	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4256190	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	177000	shares
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	177000	shares
CY2014	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	0	USD
CY2013	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	35000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21197	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7452	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1482344	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	969967	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27839	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	387000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	1454505	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	582967	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5028645	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4269169	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5058421	shares
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	55230	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	22540	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	416083	USD
CY2014	us-gaap	Interest Paid InterestPaid	563368	USD
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4289818	shares
CY2014	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	41735	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	28767	USD
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-373219	USD
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	104963	USD
CY2013	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6957996	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	35578	USD
CY2014	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	42283	USD
CY2013	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	11141	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8634	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-217	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	106556	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13337	USD
CY2014	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	-112758	USD
CY2013	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	-9775	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1278450	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	785757	USD
CY2014	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	22585990	USD
CY2013	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	15159450	USD
CY2014	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	13248464	USD
CY2013	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	14088866	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-9209793	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1070584	USD
CY2014	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	3500000	USD
CY2013	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	1770000	USD
CY2014	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	USD
CY2013	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	99363	USD
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	500000	USD
CY2014	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4288765	USD
CY2013	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2014	us-gaap	Payments Of Dividends PaymentsOfDividends	853499	USD
CY2013	us-gaap	Payments Of Dividends PaymentsOfDividends	128020	USD
CY2014	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	32500	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1065157	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-973347	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	780330	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240693	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	283084	USD
CY2013	us-gaap	Interest Paid InterestPaid	400925	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	8478985	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35578	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	22540	USD
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	99363	USD
CY2013	us-gaap	Dividends Dividends	128020	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28767	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	55230	USD
CY2014	us-gaap	Dividends Dividends	853499	USD
CY2014Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount Commercial LoansAndLeasesReceivableGrossCarryingAmountCommercial	24032476	USD
CY2013Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount Commercial LoansAndLeasesReceivableGrossCarryingAmountCommercial	14694950	USD
CY2014Q4	loan	Jointly Funded Loans JointlyFundedLoans	2665000	USD
CY2013Q4	loan	Jointly Funded Loans Total JointlyFundedLoansTotal	2400000	USD
CY2013Q4	loan	Jointly Funded Loans JointlyFundedLoans	1650000	USD
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><i><font style="COLOR: black; FONT-SIZE: 10pt">Use of Estimates</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 45pt; size: 8.5in 11.0in" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management will base the use of estimates on (a) a preset number of assumptions that consider past experience, (b) future projections, and (c) general financial market condition. Actual amounts could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2011Q1	loan	Option Monthly Fee OptionMonthlyFee	10530	USD
CY2011Q4	loan	Exercise Price Of Remaining Property ExercisePriceOfRemainingProperty	146821	USD
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><i><font style="COLOR: black; FONT-SIZE: 10pt"> Concentrations of Credit Risk</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><i><font style="COLOR: black; FONT-SIZE: 10pt">  </font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash and cash equivalents with one major financial institution. Accounts at the financial institution are insured by the Federal Deposit Insurance Corporation up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">Credit risks associated with short term commercial loans the Company makes to small businesses and related interest receivable are described in Note 4 entitled Commercial Loans.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2011Q4	loan	Monthly Option Fee For Property After Partial Exercise Of Option MonthlyOptionFeeForPropertyAfterPartialExerciseOfOption	2296	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.53
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.92
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.51
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.83
CY2013Q4	loan	Commercial Loans Issued To Borrowers CommercialLoansIssuedToBorrowers	3750950	USD
CY2013Q4	loan	Aggregate Percentage Of Commercial Loans Issued AggregatePercentageOfCommercialLoansIssued	0.255	pure
CY2014Q4	loan	Jointly Funded Loans Total JointlyFundedLoansTotal	5105000	USD
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	29776	shares
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	20649	shares
CY2014Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	51224	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	262351	shares
CY2014	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P15Y
CY2013Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	147000	USD
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.01
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.01
CY2014	loan	Sharebased Compensation Arrangement By Share Based Payment Award Options Non Vested Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedOutstandingWeightedAverageRemainingContractualTerm	P1Y10M17D
CY2012	loan	Sharebased Compensation Arrangement By Share Based Payment Award Options Non Vested Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedOutstandingWeightedAverageRemainingContractualTerm	P3Y10M17D
CY2013	loan	Sharebased Compensation Arrangement By Share Based Payment Award Options Non Vested Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedOutstandingWeightedAverageRemainingContractualTerm	P2Y10M17D
CY2013	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedGrantsInPeriodWeightedAverageRemainingContractualTerm	P4Y6M
CY2011Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	675000	USD
CY2011Q1	loan	Option Sold OptionSold	3900	USD
CY2014	us-gaap	Defined Contribution Plan Number Of Employees Covered DefinedContributionPlanNumberOfEmployeesCovered	100	pure
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	306900	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	80100	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	387000	USD
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	3000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	28000	shares
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	29000	shares
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2000	shares
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21000	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	22000	shares
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.01
CY2014	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedGrantsInPeriodWeightedAverageRemainingContractualTerm	P4Y6M
CY2013	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Vested In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedVestedInPeriodWeightedAverageRemainingContractualTerm	P4Y5M8D
CY2014	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Vested In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedVestedInPeriodWeightedAverageRemainingContractualTerm	P4Y4M17D
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	82000	shares
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	81000	shares
CY2014	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y8M5D
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.68
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.69
CY2013Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	105200	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	8766	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	78388	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	192354	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	192354	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0959	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0261	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.595	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.750	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0171	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0107	pure
CY2013	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	80000	USD
CY2014	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	146821	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2013	loan	Effective Income Tax Rate Reconciliation State And Local Franchise Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalFranchiseTaxes	0	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.4	pure
CY2014	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	13065	USD
CY2011Q3	loan	Fair Value Of Restricted Shares Granted FairValueOfRestrictedSharesGranted	195968	USD
CY2014	loan	Fair Value Of Restricted Shares Amortization Period FairValueOfRestrictedSharesAmortizationPeriod	P15Y
CY2014	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	9400	USD
CY2013	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	3800	USD
CY2014	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors	Under our stock option plan, every non-employee director of the Company is granted 7,000 options upon first taking office, and then 7,000 upon each additional year in office. Generally, options outstanding vest over periods not exceeding four years and are exercisable for up to five years from the grant date
CY2010Q4	loan	Senior Long Term Notes Under Private Placement SeniorLongTermNotesUnderPrivatePlacement	500000	USD
CY2010Q4	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	750000	USD
CY2010	loan	Common Stock Issued To Underwriter Value CommonStockIssuedToUnderwriterValue	11683	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	41400	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	28100	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	69500	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	42000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	39000	USD
CY2011	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	80000	USD
CY2011Q4	loan	Amount Of Personal Guarantee Commitment Provided By Defendant AmountOfPersonalGuaranteeCommitmentProvidedByDefendant	5000000	USD
CY2013	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19088	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2014	loan	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4288764	USD
CY2012Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	100000	shares
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000000	USD
CY2014	loan	Description Real Estate Investment Trust DescriptionRealEstateInvestmentTrust	return. A REIT calculates taxable income similar to other domestic corporations, with the major difference being aREIT is entitled to a deduction for dividends paid. A REIT is generally required to distribute each year at least 90% of its taxable income. If it chooses to retain the remaining 10% of taxable income, it may do so, but it will be subject to a corporate tax on such income. The Company
CY2011	loan	Operating Lease Term Of Lease OperatingLeaseTermOfLease	five years and two months
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	8539	USD
CY2013	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	13065	USD
CY2014	loan	Share Based Compensation Expense ShareBasedCompensationExpense	28767	USD
CY2013	loan	Share Based Compensation Expense ShareBasedCompensationExpense	35578	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	19300	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	27839	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD

Files In Submission

Name	View Source	Status
0001144204-15-017617-index-headers.html	Edgar Link	pending
0001144204-15-017617-index.html	Edgar Link	pending
0001144204-15-017617.txt	Edgar Link	pending
0001144204-15-017617-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
loan-20141231.xml	Edgar Link	completed
loan-20141231.xsd	Edgar Link	pending
loan-20141231_cal.xml	Edgar Link	unprocessable
loan-20141231_def.xml	Edgar Link	unprocessable
loan-20141231_lab.xml	Edgar Link	unprocessable
loan-20141231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sig1.jpg	Edgar Link	pending
sig2.jpg	Edgar Link	pending
tlogo.jpg	Edgar Link	pending
v404003_10k.htm	Edgar Link	pending
v404003_ex16-1.htm	Edgar Link	pending
v404003_ex23-1.htm	Edgar Link	pending
v404003_ex23-2.htm	Edgar Link	pending
v404003_ex31-1.htm	Edgar Link	pending
v404003_ex31-2.htm	Edgar Link	pending
v404003_ex32-1.htm	Edgar Link	pending
v404003_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan

2014 Form 10-K Financial Statement

#000114420415017617 Filed on March 23, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN MANHATTAN BRIDGE CAPITAL, INC Stock $loan

2014 Form 10-K Financial Statement

#000114420415017617 Filed on March 23, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan